ArticleAnti-Epithelial Growth Factor Receptors for Prognosis in Management of Metastatic Colorectal Cancer
ArticleAnti-Epithelial Growth Factor Receptors for Prognosis in Management of Metastatic Colorectal Cancer
ArticleDoes the number of metastatic organ involvement affect the response to irinotecan-based chemotherapy in patients with metastatic colorectal
ArticleDoes the number of metastatic organ involvement affect the response to irinotecan-based chemotherapy in patients with metastatic colorectal
ArticleCyclo-oxygenase-2 and vascular endothelial growth factor expression in colorectal cancer patients
ArticleCyclo-oxygenase-2 and vascular endothelial growth factor expression in colorectal cancer patients
ArticleRole of dihydropyrimidine dehydrogenase genetic polymorphism and vitamin D assay for 5-Fluorouracil therapy in Upper Egypt colorectal cancer patients
ArticleRole of dihydropyrimidine dehydrogenase genetic polymorphism and vitamin D assay for 5-Fluorouracil therapy in Upper Egypt colorectal cancer patients
ArticleColorectal Cancer Risk Factors: Insights into the Significance of Modifiable Environmental and Nutritional Lifestyle Factors
ArticleColorectal Cancer Risk Factors: Insights into the Significance of Modifiable Environmental and Nutritional Lifestyle Factors
ArticleERCC1, as Prognostic and Predictive Marker in Metastatic Colorectal Cancer Patients Treated with Oxaliplatin based Chemotherapy
ArticleERCC1, as Prognostic and Predictive Marker in Metastatic Colorectal Cancer Patients Treated with Oxaliplatin based Chemotherapy